Evaluation of serum procalcitonin and interleukin-6 levels as markers of liver metastasis
- 31 March 2007
- journal article
- Published by Elsevier in Clinical Biochemistry
- Vol. 40 (5-6) , 336-342
- https://doi.org/10.1016/j.clinbiochem.2006.10.027
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Differentiation-dependent expression and mitogenic action of interleukin-6 in human colon carcinoma cells: Relevance for tumour progressionEuropean Journal Of Cancer, 2005
- IL‐6, its receptors and its relationship with bcl‐2 and bax proteins in infiltrating and in situ human breast carcinomaHistopathology, 2005
- Carcinoembryonic antigen induction of IL‐10 and IL‐6 inhibits hepatic ischemic/reperfusion injury to colorectal carcinoma cellsInternational Journal of Cancer, 2004
- Prostaglandin E2 Stimulates Prostatic Intraepithelial Neoplasia Cell Growth through Activation of the Interleukin-6/GP130/STAT-3 Signaling PathwayBiochemical and Biophysical Research Communications, 2002
- Calcitonin precursors are reliable markers of sepsis in a medical intensive care unitCritical Care Medicine, 2000
- Interleukin 6 Induces the Expression of Vascular Endothelial Growth FactorJournal of Biological Chemistry, 1996
- Regulation of ICAM‐1 (CD54) expression in human breast cancer cell lines by interleukin 6 and fibroblast‐derived factorsInternational Journal of Cancer, 1994
- Antitumor effects of recombinant interleukin-6 expressed in eukaryotic cellsCancer Immunology, Immunotherapy, 1993
- Regulation of Interleukin‐6 Production in Human Fetal Kupffer CellsScandinavian Journal of Immunology, 1991
- The complete sequence of human preprocalcitoninFEBS Letters, 1984